1-20 of 25
Fadi Haddad
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Achievement of Measurable Residual Disease (MRD) Negativity Supersedes Treatment Intensity in Predicting the Outcome of Patients with Acute Myeloid Leukemia

Alexandre Bazinet, Tapan M. Kadia, Nicholas Short, Gautam Borthakur, Sa A Wang, Sanam Loghavi, Jeffrey L. Jorgensen, Keyur P. Patel, Courtney D. DiNardo, Naval Daver, Yesid Alvarado, Fadi Haddad, Sherry A. Pierce, Graciela M. Nogueras González, Abhishek Maiti, Michael Andreeff, Elias Jabbour, Marina Konopleva, Xuelin Huang, Hagop Kantarjian, Farhad Ravandi
Journal: Blood
Blood (2022) 140 (Supplement 1): 2267–2269.
https://doi.org/10.1182/blood-2022-162892
Published: 2022
Journal Articles

Outcomes of Chronic Myeloid Leukemia with No Major Molecular Response within 2 Years of Tyrosine Kinase Inhibitor Therapy

Aram Bidikian, Hagop Kantarjian, Ghayas C. Issa, Farhad Ravandi, Guillermo Garcia-Manero, Gautam Borthakur, Tapan M. Kadia, Naval Daver, Nitin Jain, Naveen Pemmaraju, Courtney D. DiNardo, Fadi Haddad, Sherry A. Pierce, Elias Jabbour, Koji Sasaki
Journal: Blood
Blood (2022) 140 (Supplement 1): 9626–9628.
https://doi.org/10.1182/blood-2022-167232
Published: 2022
Journal Articles

Outcome of Third-Line Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia in Chronic Phase: A Propensity Score Analysis

Elias Jabbour, Koji Sasaki, Ghayas C. Issa, Fadi Haddad, Guillermo Garcia-Manero, Tapan M. Kadia, William G. Wierda, Musa Yilmaz, Courtney D. DiNardo, Jeffrey Skinner, Naveen Pemmaraju, Sara E Dellasala, Sherry A. Pierce, Jorge E. Cortes, Hagop Kantarjian
Journal: Blood
Blood (2022) 140 (Supplement 1): 809–811.
https://doi.org/10.1182/blood-2022-169772
Published: 2022
Journal Articles

Clinicopathologic Characteristics and Outcome of Acute Myeloid Leukemia with (AML) with Core Binding Factor (CBF) Rearrangements: A Retrospective Study

Shehab Fareed Mohamed, Yahya Mulikandathil, Dina Sameh Soliman, Feryal Abbas, Awni Alshurafa, Mohammad Afana, Anil Yousaf Ellahie, Deena Sideeg Mudawi, Halima El Omri, Amna Gameil, Tareq Abuasab, Fadi Haddad, Kalpana Singh, Nancy Kassem, Honar Cherif
Journal: Blood
Blood (2022) 140 (Supplement 1): 11651–11652.
https://doi.org/10.1182/blood-2022-167176
Published: 2022
Journal Articles

A Comparative Study between Acute Myeloid Leukemia in Adolescent and Young Adults (AYA) Versus Non-AYA Patients: Single Center Experience

Shehab Fareed Mohamed, Awni Alshurafa, Dina Sameh Soliman, Halima El Omri, Deena Sideeg Mudawi, Mohamed A Yassin, Mohammad Afana, Hesham Elsabah, Anil Yousaf Ellahie, Nancy Kassem, Tareq Abuasab, Fadi Haddad, Samah Kohla, Aliaa Amer, Kalpana Singh, Honar Cherif
Journal: Blood
Blood (2022) 140 (Supplement 1): 11646–11648.
https://doi.org/10.1182/blood-2022-165462
Published: 2022
Journal Articles

More Than Ten Years Follow-up of Frontline Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Myeloid Leukemia

Fadi Haddad, Koji Sasaki, Ghayas C. Issa, Kunhwa Kim, Jeffrey Skinner, Sara E Dellasala, Yesid Alvarado, Alessandra Ferrajoli, Tapan M. Kadia, Musa Yilmaz, Naveen Pemmaraju, Guillermo Garcia-Manero, Sherry A. Pierce, Elias Jabbour, Hagop Kantarjian
Journal: Blood
Blood (2022) 140 (Supplement 1): 3897–3899.
https://doi.org/10.1182/blood-2022-168604
Published: 2022
Journal Articles

Prognostic Model of Transformation to Blast Phase in Patients with Chronic Myeloid Leukemia

Alex Bataller, Koji Sasaki, Elias Jabbour, Ghayas C. Issa, Fadi Haddad, Jeffrey Skinner, Sara E Dellasala, Guillermo Garcia-Manero, Sherry A. Pierce, Hagop Kantarjian
Journal: Blood
Blood (2022) 140 (Supplement 1): 3895–3896.
https://doi.org/10.1182/blood-2022-164924
Published: 2022
Journal Articles

Long-Term Follow-up of Low-Dose Dasatinib (50mg Daily) As Frontline Therapy in Newly Diagnosed Chronic Myeloid Leukemia

Georgina Gener-Ricos, Fadi Haddad, Koji Sasaki, Ghayas C. Issa, Jeffrey Skinner, Koichi Takahashi, Lucia Masarova, Jan A. Burger, Gautam Borthakur, Prithviraj Bose, Guillermo Garcia-Manero, Elias Jabbour, Hagop Kantarjian
Journal: Blood
Blood (2022) 140 (Supplement 1): 1493–1494.
https://doi.org/10.1182/blood-2022-167764
Published: 2022
Journal Articles

A Descriptive Analysis of TP53 Y220C Mutations in Patients with Hematologic Malignancies

Georgina Gener-Ricos, Koji Sasaki, Sanam Loghavi, Abhishek Maiti, Nicholas Short, Fadi Haddad, Naval Daver, Gautam Borthakur, Farhad Ravandi, Hagop Kantarjian, Keyur P. Patel, Michael Andreeff, Courtney D. DiNardo
Journal: Blood
Blood (2022) 140 (Supplement 1): 11830–11832.
https://doi.org/10.1182/blood-2022-167923
Published: 2022
Journal Articles

Baseline Liver Elastography Does Not Predict Risks of Hepato-Toxicity to Reduced Dose Inotuzumab Therapy Combined with Minihcvd in B-Cell Acute Lymphoblastic Leukemia

Jayastu Senapati, Nicholas Short, Nitin Jain, Farhad Ravandi, Tharakeswara K. Bathala, Aram Bidikian, Fadi Haddad, Patrice Nasnas, Naval Daver, Tapan M. Kadia, Rebecca Garris, Monica Kwari, Hagop Kantarjian, Elias Jabbour
Journal: Blood
Blood (2022) 140 (Supplement 1): 3182–3184.
https://doi.org/10.1182/blood-2022-170931
Published: 2022
Journal Articles

Evaluation of Emergent FLT3 Mutations (FLT3m) at Relapse in Patients (Pts) with Wild-Type FLT3 Acute Myeloid Leukemia (AML)

Fadi Haddad, Georgio Medawar, Rashmi Kanagal-Shamanna, Hector Alvarez, Sanam Loghavi, Naval Daver, Sherry A. Pierce, Elias Jabbour, Tapan M. Kadia, Nicholas Short, Courtney D. DiNardo, Gautam Borthakur, Hussein A Abbas, Naveen Pemmaraju, Guillermo Garcia-Manero, Farhad Ravandi, Hagop Kantarjian, Musa Yilmaz
Journal: Blood
Blood (2022) 140 (Supplement 1): 3196–3198.
https://doi.org/10.1182/blood-2022-169991
Published: 2022
Journal Articles

Characteristics and Outcomes of Adolescent and Young Adult (AYA) Patients with Acute Myeloid Leukemia (AML): A Single Center Experience

Shehab Fareed Mohamed, Mohammad Afana, Dina Sameh Soliman, Feryal Abbas, Halima El Omri, Tareq Abuasab, Fadi Haddad, Mohamed A Yassin, Deena Sideeg Mudawi, Hesham Elsabah, Samah Kohla, Aliaa Amer, Yahya Mulikandathil, Amna Gameil, Awni Alshurafa, Kalpana Singh, Honar Cherif
Journal: Blood
Blood (2022) 140 (Supplement 1): 11661–11662.
https://doi.org/10.1182/blood-2022-163341
Published: 2022
Journal Articles

Ponatinib and Blinatumomab for Patients with Relapsed/Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Chronic Myeloid Leukemia in Lymphoid Blast Phase: A Subgroup Analysis from a Phase II Study

Walid Macaron, Hagop Kantarjian, Nicholas Short, Nitin Jain, Xuelin Huang, Guillermo Montalban-Bravo, Tapan M. Kadia, Naval Daver, Kelly S. Chien, Yesid Alvarado, Guillermo Garcia-Manero, Ghayas C. Issa, Fadi Haddad, Monica Kwari, Ricardo Delumpa, Ejiroghene Mayor, Wuliamatu Deen, Jennifer Thankachan, Christopher Loiselle, Juan Rivera, Anna Milton, Lourdes Waller, Glenda Banks, Rebecca Garris, Marina Konopleva, Farhad Ravandi, Elias Jabbour
Journal: Blood
Blood (2022) 140 (Supplement 1): 8973–8975.
https://doi.org/10.1182/blood-2022-157323
Published: 2022
Journal Articles

Hematoma or Bleeding As Initial Presentation of Chronic Myeloid Leukemia (CML): Review

Ashraf Ahmed, Sara Saeed, Dina Sameh Soliman, Fadi Haddad, Tareq Abuasab, Feryal Abbas, Mohammad Abdul-Jaber Abdulla, Shehab F Mohamed
Journal: Blood
Blood (2022) 140 (Supplement 1): 12231–12232.
https://doi.org/10.1182/blood-2022-160132
Published: 2022
Journal Articles

Improved Outcomes with Low-Dose Inotuzumab and Mini-Hyper-CVD Followed By Blinatumomab Consolidation in Relapsed-Refractory Acute Lymphoblastic Leukemia: Results of a Phase II Study

Fadi Haddad, Elias Jabbour, Nicholas Short, Nitin Jain, Emmanuel Almanza Huante, Koji Sasaki, Patrice Nasnas, Farhad Ravandi, Partow Kebriaei, Xuelin Huang, Marina Konopleva, Guillermo Garcia-Manero, Richard E Champlin, Tapan M. Kadia, Koichi Takahashi, Naval Daver, Joseph D. Khoury, Jeffrey L. Jorgensen, Sa A Wang, Jovitta Jacob, Rebecca Garris, Hagop Kantarjian
Journal: Blood
Blood (2022) 140 (Supplement 1): 11698–11701.
https://doi.org/10.1182/blood-2022-170049
Published: 2022
Journal Articles

Ponatinib and Blinatumomab for Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Subgroup Analysis from a Phase II Study

Nicholas Short, Hagop Kantarjian, Nitin Jain, Xuelin Huang, Guillermo Montalban-Bravo, Tapan M. Kadia, Naval Daver, Kelly S. Chien, Yesid Alvarado, Guillermo Garcia-Manero, Ghayas C. Issa, Walid Macaron, Fadi Haddad, Monica Kwari, Ricardo Delumpa, Ejiroghene Mayor, Wuliamatu Deen, Jennifer Thankachan, Christopher Loiselle, Juan Rivera, Anna Milton, Lourdes Waller, Glenda Banks, Rebecca Garris, Marina Konopleva, Farhad Ravandi, Elias Jabbour
Journal: Blood
Blood (2022) 140 (Supplement 1): 513–515.
https://doi.org/10.1182/blood-2022-157775
Published: 2022
Journal Articles

Utility of Flow Cytometry in Monitoring of Measurable Residual Disease in Patients with Hairy Cell Leukemia

Tareq Abuasab, Fadi Haddad, Shehab Fareed Mohamed, Jeffrey L. Jorgensen, Sa A Wang, Philip A. Thompson, Tapan M. Kadia, Yesid Alvarado, Sherry A. Pierce, Michael J. Keating, David McCue, Hagop Kantarjian, Farhad Ravandi
Journal: Blood
Blood (2022) 140 (Supplement 1): 9385–9386.
https://doi.org/10.1182/blood-2022-165639
Published: 2022
Journal Articles

Myeloid Sarcoma in Myelodysplastic Syndrome : Review

Mahmood B Aldapt, Dina Sameh Soliman, Fadi Haddad, Tareq Abuasab, Feryal Abbas, Osama Mosalem, Ashraf Ahmed, Sara Saeed, Hawraa Shwaylia, Mohammad Abdul-Jaber Abdulla, Shehab Fareed Mohamed
Journal: Blood
Blood (2022) 140 (Supplement 1): 12333–12334.
https://doi.org/10.1182/blood-2022-163324
Published: 2022
Journal Articles

Extramedullary Hematopoiesis (EMH) and Myelodysplastic Syndrome (MDS): Review

Mahmood B Aldapt, Fadi Haddad, Tareq Abuasab, Dina Sameh Soliman, Feryal Abbas, Osama Mosalem, Ashraf Ahmed, Sara Saeed, Mohammad Abdul-Jaber Abdulla, Shehab Fareed Mohamed
Journal: Blood
Blood (2022) 140 (Supplement 1): 12331–12332.
https://doi.org/10.1182/blood-2022-163298
Published: 2022
Journal Articles

A Phase II Study of Blinatumomab for the Treatment of Measurable Residual Disease-Positive B-Cell Acute Lymphoblastic Leukemia

Fadi Haddad, Hagop Kantarjian, Nicholas J. Short, Marina Konopleva, Nitin Jain, Farhad Ravandi, Naval Daver, Yesid Alvarado, Koichi Takahashi, Guillermo Garcia-Manero, Michelle Velasquez, Rebecca Garris, Elias J. Jabbour
Journal: Blood
Blood (2021) 138 (Supplement 1): 4398.
https://doi.org/10.1182/blood-2021-149261
Published: 2021